Basic & Clinical Pharmacology & Toxicology

Bone Anabolic Treatment in Patients With Chronic Kidney Disease: A Systematic Review

By Huriye Seyma Kafa, Sabina Chaudhary Hauge, Ditte Hansen

Systematic review of randomised trialsInterventions

The paper

Huriye Seyma Kafa, Sabina Chaudhary Hauge, Ditte Hansen

Herlev Hospital; University of Copenhagen

Basic & Clinical Pharmacology & Toxicology, 2 Oct 2026

doi.org/10.1111/bcpt.70293 PubMed 42825520

Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
The American Journal of Cardiology8 Oct 2026
Drug class linked to fewer deaths or complications in kidney disease
Internal and Emergency Medicine4 Oct 2026
ARNI links to lower osteoporosis risk in heart failure